Interview with Professor Juan Miguel Bayo Fina from the Faculty of Biomedical Sciences of the Universidad Austral and an adjunct researcher at CONICET and the Institute of Translational Medicine Research at Radio Atlántica, on a new experimental therapeutic strategy that could benefit patients with severe liver diseases. In a significant advance for translational science in Argentina, researchers from the Laboratory of Experimental Hepatology and Gene Therapy (IIMT) identified for the first time an effective therapeutic pathway to treat fulminant hepatitis, a condition that can cause death in up to 40% of cases without transplantation.